Rallis India shares soared to a record high of ₹373.80 apiece on the BSE on Wednesday, October 15, marking a significant 16.2% jump. This rally came on the heels of the company's announcement of robust financial results for the September 2024 quarter (Q2 FY25), which exceeded market expectations.
Strong growth in net profit boosts investor confidence
The company's net profit for the quarter surged by 19.51% to ₹98 crore, compared to ₹82 crore during the same period last year. The notable growth in profitability, coupled with a 14.29% increase in the stock price to ₹367.55 at the time of writing, attracted many looking to invest in stocks. Rallis India, a subsidiary of Tata Chemicals and part of the Tata Group, continues to cement its reputation as a leading player in the agricultural sector.
Revenue growth supported by domestic market performance
Revenue from operations reached ₹928 crore, reflecting an 11.5% growth from ₹832 crore in the corresponding quarter of the previous fiscal year. This growth was driven by double-digit expansion in the domestic market, particularly in the crop care and seeds segments. "We had a strong second quarter performance in FY25, helped by double-digit growth in the domestic market," said Rallis India Managing Director and CEO Dr Gyanendra Shukla.
International market challenges and outlook for the Rabi season
Despite the positive domestic results, the international market presented some hurdles. While there was a recovery in volume, pricing challenges persisted. Nevertheless, the company remains optimistic for the upcoming Rabi season, supported by high reservoir water levels across key agricultural regions. For those aiming to invest in stocks within the agricultural sector, Rallis India presents a compelling opportunity due to its diversified product range and strong market position.
Mark Plus: A new herbicide strengthening Rallis India's portfolio
In June 2024, Rallis India introduced 'Mark Plus,' a new herbicide for soybean and groundnut crops. Initially launched in Maharashtra, Madhya Pradesh, and Gujarat, the product is set for a nationwide rollout.
Mark Plus contains two active ingredients not previously used in India, working to inhibit essential enzymes for weed growth. The product's introduction is anticipated to bolster the company's growth prospects further, potentially attracting more investors looking to invest in stocks within the agricultural input sector.
Earnings per share and market capitalisation
The company's basic and diluted earnings per share stood at ₹5.04 for the September quarter, up from ₹4.23 in the same period the previous year. As of now, Rallis India's market capitalisation is approximately ₹7,147.70 crore, reflecting the company's strong financial standing. Investors interested in long-term growth may find this stock attractive as they look to invest in stocks with potential in the agricultural domain.
Conclusion
Rallis India's impressive Q2 results and all-time high share price underscore the company's resilience and growth potential. With a strong domestic market performance, innovative product launches, and a promising outlook for the rabi season, the company presents a noteworthy opportunity for those looking to invest in stocks. As Rallis India continues to expand its product offerings and navigate international market challenges, its growth trajectory appears robust.
For android only